Stellar Biotechnologies Inc.

Stellar Biotechnologies is the world leader in sustainable manufacture of keyhole limpet hemocyanin (KLH). The company serves the growing demand for this essential molecule and is focused on applying its expertise to targeted therapeutics and immunodiagnostics. The company was founded to address the urgent need for sustained commercial-scale supplies of high-quality keyhole limpet hemocyanin (KLH) and has developed leading practices, facilities and proprietary capabilities to address this need. Stellar Biotechnologies has generated important intellectual property that relates to aquaculture technologies, spawning, selection and maintenance of the limited natural source of Megathura crenulata, an important pharmaceutical material, as well as processing, purification and engineering of specific stabilized formulations of this valuable protein. Stellar has generated revenue since 2001 and its customers and partners include multinational pharmaceutical companies, world-renowned laboratories and research centers, as well as biotechnology companies and vaccine developers.